OakChart

Teladoc Health Inc

TDOCHealthcare·Health Information Services·USA·Small·NYSE·Nov 11 • 2:01 PM ET

9.10+0.16 (1.73%)
2026-11-11 20:01 CET
Market cap
1,629.71 USD m
Revenue, TTM
2,468.14 USD m
Net income, TTM
-154.82 USD m
Free cash flow, TTM
261.96 USD m
EPS diluted, TTM
-0.86
P/E
-
Compare

Price

TDOC against its 20, 50 and 200-day averages
2050200beat
6.008.0010.0013.2M26.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TDOCclose 9.1020-day 7.5950-day 6.67200-day 6.589.1052w high

8.0% under the 52-week high of 9.89 on 16 Jul 2026. 52-week low 4.40 on 12 Feb 2026. Last 15 sessions, 59.4% high to low

Profile

TDOC
52-week range, 86% of the way up
4.409.89

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

IndexRUT
Employees5600
IPOJul 01, 2015
Beta1.96
ATR, 14d0.50
Rel volume0.56
Short float17.79%
Insider own0.72%
Inst own86.37%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.66B
Enterprise Value1.84B
Income-154.82M
Sales2.47B
Book/sh7.10
Cash/sh4.66
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees5600
IPOJul 01, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S0.67
P/B1.28
P/C1.95
P/FCF6.33
EV/EBITDA7.51
EV/Sales0.75
Quick Ratio0.82
Current Ratio0.84
Debt/Eq0.80
LT Debt/Eq0.02
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.86
EPS next Y-0.61
EPS next Q-0.11
EPS this Y27.01%
EPS next Y26.32%
EPS next 5Y22.60%
EPS past 3/5Y76.23% 26.67%
Sales past 3/5Y1.68% 18.26%
EPS Y/Y TTM32.73%
Sales Y/Y TTM-2.38%
EPS Q/Q47.07%
Sales Q/Q-3.41%
EarningsOct 28 AMC
EPS/Sales Surpr.30.97% 2.88%

Ownership

Insider Own0.72%
Insider Trans-11.48%
Inst Own86.37%
Inst Trans6.76%
ROA-5.48%
ROE-11.52%
ROIC-11.70%
Gross Margin53.64%
Oper. Margin-5.36%
Profit Margin-6.27%
SMA2019.86%
SMA5036.38%
SMA20038.18%
Trades-

Technical

Shs Outstand182.25M
Shs Float180.97M
Short Float17.79%
Short Ratio7.67
Short Interest32.19M
52W High9.89 -8.01%
52W Low4.40 106.70%
Volatility7.59% 6.35%
ATR (14)0.50
RSI (14)69.29
Beta1.96
Rel Volume0.56
Avg Volume4.20M
Volume1,661,795

Performance

Perf Week-6.24%
Perf Month51.58%
Perf Quarter30.68%
Perf Half Y33.95%
Perf YTD29.93%
Perf Year20.30%
Perf 3Y-42.98%
Perf 5Y-93.29%
Perf 10Y-49.19%
Recom2.60
Target Price8.71
Prev Close8.94
Price9.10
Change %1.73%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 02, 2026DowngradeAArgusHold → Sell
Mar 10, 2026UpgradeDDeutsche BankHold → Buy$11+20.9%
Feb 26, 2026UpgradeBBofA SecuritiesNeutral → Buy$7-23.0%
Dec 09, 2025InitiatedBBarclaysEqual Weight$8.50-6.5%
Nov 13, 2025InitiatedBBMO Capital MarketsMarket Perform$8-12.0%
Jul 25, 2025InitiatedMMizuhoNeutral$10+10.0%
Nov 15, 2024InitiatedGGoldmanBuy$14+53.9%
Sep 17, 2024ReiteratedJJefferiesHold$8 → $10+10.0%
Feb 29, 2024InitiatedCCantor FitzgeraldOverweight$22+141.9%
Feb 26, 2024InitiatedLLeerink PartnersMarket Perform$17+86.9%

Peers

Mkt cap
TickerCompanyMkt cap
AMWLAmerican Well Corp210.52M
OMDAOmada Health Inc968.41M
LFMDLifeMD Inc81.70M
HNGEHinge Health Inc9.59B
HIMSHims & Hers Health Inc4.82B
DRIODarioHealth Corp22.24M
DOCSDoximity Inc5.94B
GDRXGoodRx Holdings Inc1.23B
LFSTLifeStance Health Group Inc5.43B
HQYHealthequity Inc8.52B

Insider trading

latest 14 of 64
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Nueno CarlosPresident, InternationalNov 06 '26Sale9.2029,432270,77435,312Nov 09 04:33 PM
Nueno CarlosOfficerNov 06 '26Proposed Sale9.2029,432270,774Nov 06 09:43 AM
Catapano Joseph RonaldChief Accounting OfficerOct 02 '26Sale5.656553,70314,293Oct 05 04:05 PM
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERSep 11 '26Sale6.1017,805108,682465,535Sep 14 04:05 PM
DIVITA CHARLES IIIOfficerSep 11 '26Proposed Sale6.1017,805108,684Sep 11 03:14 PM
Nueno CarlosPresident, InternationalSep 02 '26Sale6.306,20039,06664,744Sep 03 04:06 PM
Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARYSep 02 '26Sale6.307,57347,717117,616Sep 03 04:05 PM
Bliss KellyPresident, U.S. Group HealthSep 02 '26Sale6.307,35746,35692,832Sep 03 04:05 PM
Catapano Joseph RonaldChief Accounting OfficerSep 02 '26Sale6.302741,72612,865Sep 03 04:05 PM
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERSep 02 '26Sale6.3018,327115,478440,538Sep 03 04:05 PM
Rodrigues Fernando M.OfficerSep 03 '26Proposed Sale6.519,81263,876Sep 03 11:45 AM
Bliss KellyOfficerSep 02 '26Proposed Sale6.307,35746,359Sep 02 04:02 PM
Rodrigues Fernando M.OfficerSep 02 '26Proposed Sale6.305,43934,273Sep 02 04:01 PM
Vandervoort Adam COfficerSep 02 '26Proposed Sale6.307,57347,720Sep 02 03:57 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
CPAICounterpoint Quantitative Equity ETFAUM: 537.19M
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200
  • Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire) +9.11%
  • Teladoc Beats On Cost Discipline And BetterHelp Insurance Ramp, But Revenue Is Still Shrinking (Earnings Whispers) +26.89%
  • Teladoc Health Reports Third Quarter 2026 Results (GlobeNewswire) +6.67%
  • Teladoc's BetterHelp Reset Faces First Test As Insurance Ramp Races Cash-Pay Decline (Earnings Whispers) +8.38%
  • Teladoc Health to Announce Third Quarter 2026 Financial Results (GlobeNewswire)
  • Teladoc unveils remote monitoring, ambient AI features (Healthcare Dive)
  • Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery (GlobeNewswire)
  • Teladoc Health Announces Chief Legal Officer Transition (GlobeNewswire)
  • Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? (Trefis)
  • Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
  • Teladoc Health Appoints Michael Grasher as Chief Financial Officer (GlobeNewswire)
  • Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
  • Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors (GlobeNewswire)
  • ?? Under the Radar: Teladoc Shares Tumble on Therapist Shortage (The Wall Street Journal) -28.32%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-28-0.150-0.217-0.150605.1588.1416
2026Q22026-07-29-0.210-0.250-0.215606.93615.4416
2026Q12026-04-29-0.360-0.341-0.356613.85610.8519
2025Q42026-02-25-0.140-0.181-0.141642.27635.3120
2025Q32025-10-29-0.280-0.264-0.280626.44625.7620
2025Q22025-07-29-0.190-0.258-0.186631.9622.5419
2025Q12025-04-30-0.530-0.343-0.534629.37619.221
2024Q42025-02-26-0.280-0.260-0.280640.49639.5520
2024Q32024-10-30-0.190-0.277-0.194640.51631.1822
2024Q22024-07-31-4.920-0.345-4.921642.44649.1620
2024Q12024-04-25-0.490-0.459-0.488646.13637.3122
2023Q42024-02-20-0.170-0.219-0.174660.53670.8117
2023Q32023-10-24-0.350-0.365-0.346660.24663.5421
2023Q22023-07-25-0.400-0.407-0.397652.41649.1823
2023Q12023-04-26-0.420-0.484-0.425629.24619.321
2022Q42023-02-22-23.490-0.246-23.494637.71633.422

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.380-1.445-1.376553.31550.02
2020FY-5.360-1.373-5.3601,0941,090
2021FY-2.730-3.254-2.7322,0332,026
2022FY-84.600-61.259-84.6022,4072,402
2023FY-1.340-1.377-1.3392,6022,613
2024FY-5.870-5.817-5.8702,5702,569
2025FY-1.140-1.179-1.1402,5302,523
2026FY--0.832--2,422
2027FY--0.613--2,356
2028FY--0.529--2,383
2029FY--0.193--2,424
2030FY-0.155--2,556

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-062125596.6586612.57
2026Q4S2026-11-032115595.28571.58612.57
2026Q4S2026-10-302115595.38571.58612.57
2026Q4S2026-10-292015595.44571.58612.57
2026Q4S2026-10-282003596.75571.58609.2
2026Q4S2026-10-262003596.75571.58609.2
2026Q4S2026-10-242004596.75571.58609.2
2026Q4S2026-10-232005596.75571.58609.2
2026Q4S2026-10-172004597.4571.58609.2
2026Q4S2026-10-142006597.4571.58609.2
2026Q4S2026-10-132007597.4571.58609.2
2026Q4S2026-10-0220020597.4571.58609.2
2026Q4S2026-09-2820019599.81571.58642.1
2026Q4S2026-09-2520019599.81571.58642.1

Estimate history

EPS, annual-1.927-1.474-1.376-5.36-2.732-84.602-1.339-5.87-1.137-0.8608
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.194-0.28-0.534-0.186-0.28-0.141-0.356-0.215-0.148
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual233.279417.907553.3071093.9622032.7072406.842602.4152569.5742529.9772468.14
Period201720182019202020212022202320242025TTM
Sales, quarterly640.508640.491629.369631.9626.439642.269613.845606.927605.102
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual61.53470.51672.762150.281160.469162.84166.658173.405178.315182.254
Period201720182019202020212022202320242025MRQ
Shares, quarterly171.944173.405175.34176.608177.35178.315180.431181.65182.254
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,468.142,529.982,569.572,602.412,406.842,032.711,093.96553.31417.91
Cost of Goods Sold Incl. D&A1,144.181,135.671,124.821,097.101,000.01854.50460.32223.42164.34
Gross Profit1,323.971,394.311,444.761,505.311,406.831,178.21633.64329.89253.57
Selling, General and Administrative Excl. Other1,456.291,557.701,653.541,715.811,634.191,417.201,042.95396.95315.63
Research and Development267.88277.92307.27348.52333.63311.88164.9464.6454.37
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-132.32-163.40-208.79-210.50-227.37-238.99-409.31-67.06-62.06
Interest Expense20.3619.7123.8022.289.2780.3659.9029.0126.11
Unusual Expense30.6399.56812.1038.0513,425.8570.39106.1913.3814.29
Net Income Before Taxes-158.65-235.53-993.65-219.61-13,663.34-384.66-575.99-109.45-96.97
Income Taxes-3.83-35.217.590.76-3.8144.14-90.86-10.590.12
Consolidated Net Income-154.82-200.32-1,001.25-220.37-13,659.53-428.79-485.14-98.86-97.08
Net Income From Continuing Operations-154.82-200.32-1,001.25-220.37-13,659.53-428.79-485.14-98.86-97.08
Net Income-154.82-200.32-1,001.25-220.37-13,659.53-428.79-485.14-98.86-97.08
EPS (Recurring)-0.73-0.74-2.54-1.18-26.39-2.42-4.54-1.25-1.32
EPS (Basic, Before Extraordinaries)-0.86-1.14-5.87-1.34-84.60-2.73-5.36-1.38-1.47
EPS (Diluted)-0.86-1.14-5.87-1.34-84.60-2.73-5.36-1.38-1.47
EBITDA245.57213.04174.06140.8243.28-19.37-331.22-28.11-26.46
Non-Operating Income (Expense)24.6747.1451.0451.23-0.865.09-0.600.005.50
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense41.6569.49125.35174.58172.10-220.89347.1448.6934.58
Price To Sales Ratio0.430.490.601.361.597.0916.5410.877.81
Gross Margin53.6455.1156.2357.8458.4557.9657.9259.6260.68
Operating Margin-5.36-6.46-8.13-8.09-9.45-11.76-37.42-12.12-14.85
Net Margin-6.27-7.92-38.97-8.47-567.53-21.09-44.35-17.87-23.23
Shares Outstanding182.25178.32173.41166.66162.84160.47150.2872.7670.52
Market Capitalization1,629.711,629.711,565.003,567.753,829.5714,699.1928,986.406,059.823,475.20

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue605.10606.93613.85642.27626.44631.90629.37640.49
Cost of Goods Sold Incl. D&A280.73281.75289.81291.89275.55283.54284.70278.45
Gross Profit324.37325.18324.03350.38350.89348.36344.67362.04
Selling, General and Administrative Excl. Other346.50359.68372.76377.35386.35394.40399.61404.20
Research and Development65.5562.8667.8671.6167.5768.7869.9676.75
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-22.13-34.50-48.73-26.97-35.46-46.03-54.94-42.16
Interest Expense4.935.115.374.954.534.475.766.85
Unusual Expense5.972.5913.049.0316.518.3565.676.06
Net Income Before Taxes-26.28-37.91-60.84-33.62-50.22-40.42-111.27-48.17
Income Taxes0.661.003.00-8.47-0.71-7.76-18.250.24
Consolidated Net Income-26.93-38.91-63.84-25.14-49.51-32.66-93.01-48.41
Net Income From Continuing Operations-26.93-38.91-63.84-25.14-49.51-32.66-93.01-48.41
Net Income-26.93-38.91-63.84-25.14-49.51-32.66-93.01-48.41
EPS (Recurring)-0.13-0.20-0.31-0.11-0.21-0.15-0.27-0.26
EPS (Basic, Before Extraordinaries)-0.15-0.21-0.36-0.14-0.28-0.19-0.53-0.28
EPS (Diluted)-0.15-0.21-0.36-0.14-0.28-0.19-0.53-0.28
EBITDA69.9557.9145.4672.2556.7048.8535.2349.51
Non-Operating Income (Expense)6.754.296.297.336.2718.4315.116.89
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.447.6711.9612.5714.7717.6519.8821.70
Price To Sales Ratio0.430.620.390.490.540.600.540.61
Gross Margin53.6153.5852.7954.5556.0155.1354.7656.53
Operating Margin-3.66-5.68-7.94-4.20-5.66-7.29-8.73-6.58
Net Margin-4.45-6.41-10.40-3.91-7.90-5.17-14.78-7.56
Shares Outstanding182.25181.65180.43178.32177.35176.61175.34173.41
Market Capitalization1,629.711,530.75972.261,242.311,365.821,528.041,382.431,565.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments781.081,298.331,123.67918.18896.02786.57517.06478.53122.31
Short Term Receivables201.66223.96230.06235.65168.96169.2856.9543.5727.09
Inventories38.2038.1429.5156.3473.0856.500.000.000.00
Other Current Assets66.3670.3073.0975.2665.0847.2613.9910.636.84
Total Current Assets1,087.311,630.721,456.351,285.431,203.131,059.61588.00532.74156.24
Net Property, Plant & Equipment53.0956.5872.0971.4774.0175.2036.7510.158.96
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1,580.281,714.552,750.972,909.9516,414.4516,602.12971.53984.59658.33
Deferred Tax Assets242.50246.84310.66355.60467.19537.9569.55-94.01-49.40
Other Assets137.62114.68112.9678.5043.0118.366.541.400.86
Total Assets3,100.803,763.364,703.034,700.9518,201.8018,293.231,672.381,434.87774.99
Short Term Debt Incl. Current Port. of LT Debt11.04561.0610.7513.5912.6954.005.090.000.00
Accounts Payable47.9733.1343.6447.6947.2646.039.077.773.88
Income Tax Payable--0.623.823.101.632.862.61-
Other Current Liabilities345.73347.35365.61334.67267.97230.9973.1652.0636.45
Total Current Liabilities404.74941.53420.62399.77331.01332.6590.1862.4440.33
Long Term Debt1,029.131,023.551,581.531,573.331,267.441,422.73465.40414.68207.37
Provision for Risks Charges0.000.000.000.000.000.000.000.470.67
Deferred Tax Liabilities271.44296.69360.11406.54542.97640.0591.23-61.56-36.49
Other Liabilities9.7810.5114.7013.5714.6213.9911.545.724.22
Total Liabilities1,715.092,272.282,376.962,393.212,156.052,409.42658.36421.75216.09
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,385.711,491.082,326.072,307.7416,045.7615,883.801,014.021,013.12558.90
Total Shareholders Equity1,385.711,491.082,326.072,307.7416,045.7615,883.801,014.021,013.12558.90
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,385.711,491.082,326.072,307.7416,045.7615,883.801,014.021,013.12558.90
Total Liabilities & Stockholders Equity3,100.803,763.364,703.034,700.9518,201.8018,293.231,672.381,434.87774.99
Book Value Per Share7.778.6013.9614.1799.99105.6913.9414.379.08
Tangible Book Value Per Share-1.09-1.29-2.55-3.70-2.30-4.780.580.40-1.62
Full-Time Employees5,6005,5005,6005,6005,1004,4002,4002,0001,231
Price to Book Ratio1.261.041.560.630.921.896.013.454.44
Return on Assets-5.84-23.65-4.69-119.28-2.35-4.86-6.36-8.79-19.80
Return on Equity-13.93-52.46-9.51-148.85-2.69-5.74-9.75-12.35-27.04
Return on Invested Capital-8.30-39.82-5.64-351.95-2.48-2.80-6.68-6.80-13.94
Quick Ratio2.591.693.393.073.413.026.528.533.87
Current Ratio2.691.733.463.223.633.196.528.533.87

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-154.82-200.32-1,001.25-220.37-13,659.53-428.79-485.14-98.86-97.08
Depreciation377.90376.43382.84351.32270.64219.6278.0944.9535.60
Other Funds (Non Cash)60.50154.47949.54209.3313,646.99411.69534.1894.8160.00
Funds from Operations272.09289.17330.00338.38250.26244.3136.9730.02-3.73
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-3.711.07-36.3111.64-60.97-50.32-90.48-0.16-1.13
Cash from Operating Activities268.38290.25293.68350.02189.29193.99-53.5129.87-4.86
Capital Expenditures-142.26-157.02-124.05-156.35-172.76-63.93-26.04-10.90-8.41
Net Assets From Acquisitions0.00-81.900.000.000.00-78.66-567.43-11.19-282.44
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.005.53
Purchase or Sale of Investments-1.00-27.140.000.002.5160.902.5047.1027.82
Purchase of Investments-1.00-27.880.000.000.000.000.00-5.00-56.35
Sale Or Maturity of Investments0.000.740.000.002.5160.902.5052.1084.17
Other Uses0.000.000.000.00--0.000.000.00
Other Sources0.000.060.000.002.518.710.000.000.00
Cash from Investing Activities-143.25-266.00-124.05-156.35-167.74-72.98-590.9825.01-257.50
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.793.088.3111.1312.3842.5959.0436.66364.73
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.793.088.3111.1312.3842.5959.0436.66364.73
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00330.84
Issuance or Reduction of Debt, Net0.00-550.630.000.00-3.15-0.91829.440.00279.16
Change in Long Term Debt0.00-550.630.000.00-3.15-0.91829.440.00279.16
Issuance of Long Term Debt0.000.000.000.0011.8715.281,067.590.00279.16
Reduction of Long Term Debt0.00-550.630.000.00-15.02-16.19-238.150.000.00
Net Financing Active Other Cash Flow-2.850.00-0.00-0.28-2.74-0.73-29.34-1.571.72
Other Financing Activities Uses-2.850.00-0.00-0.28-2.87-0.73-35.34-1.57-
Cash from Financing Activities-0.05-547.548.3110.856.5040.95859.1435.09645.61
Exchange Rate Effect-1.416.05-3.290.96-3.34-1.804.320.39-2.08
Net Change in Cash123.66-517.24174.65205.4924.70160.16218.9790.36381.17
Free Cash Flow261.96281.36282.89338.56172.81185.46-57.5326.36-8.87
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow4.034.385.4810.4822.1077.70-228.19-
Deferred Taxes & Investment Tax Credit--41.41-1.15-1.90-7.8441.80-90.16-10.87-2.25

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments849.91774.35750.74781.08726.25679.62
Short Term Receivables241.66230.88222.54201.66219.48234.00
Inventories30.7528.8231.5638.2039.9038.16
Other Current Assets67.0879.2990.1366.3673.5887.42
Total Current Assets1,189.391,113.351,094.961,087.311,059.211,039.21
Net Property, Plant & Equipment46.2647.4150.5153.0959.2853.17
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1,400.331,458.861,518.381,580.281,619.841,666.50
Deferred Tax Assets---242.50--
Other Assets139.09139.01143.41137.62140.21135.13
Total Assets2,775.072,758.622,807.263,100.802,878.552,894.00
Short Term Debt Incl. Current Port. of LT Debt1,007.031,006.6710.5011.0410.239.88
Accounts Payable46.3437.5045.2047.9752.2054.43
Other Current Liabilities362.14337.56349.17345.73342.67337.45
Total Current Liabilities1,415.501,381.73404.87404.74405.09401.77
Long Term Debt28.1229.541,027.551,029.131,031.841,025.21
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities26.9926.8827.61271.4434.0629.95
Other Liabilities9.7310.3710.929.7815.4414.94
Total Liabilities1,480.351,448.521,470.941,715.091,486.431,471.87
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,294.721,310.111,336.321,385.711,392.121,422.14
Total Shareholders Equity1,294.721,310.111,336.321,385.711,392.121,422.14
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,294.721,310.111,336.321,385.711,392.121,422.14
Total Liabilities & Stockholders Equity2,775.072,758.622,807.263,100.802,878.552,894.00
Book Value Per Share7.107.217.417.777.858.05
Tangible Book Value Per Share-0.58-0.82-1.01-1.09-1.28-1.38
Full-Time Employees---5,600--
Price to Book Ratio1.261.150.700.890.961.07
Return on Assets-5.48-6.28-5.48-5.84-6.98-6.46
Return on Equity-11.52-12.99-12.39-13.93-15.42-14.18
Return on Invested Capital-2.04-2.90-2.70-1.04-2.04-1.33
Quick Ratio0.820.782.632.592.522.49
Current Ratio0.840.812.702.692.612.59

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-26.93-38.91-63.84-25.14-49.51-32.66
Depreciation92.0892.4194.1999.2292.1594.89
Other Funds (Non Cash)13.4511.6715.8619.5225.8822.96
Funds from Operations78.7464.5645.1583.6471.1477.98
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital27.720.11-35.634.1024.0113.45
Cash from Operating Activities106.4664.669.5287.7495.1691.43
Capital Expenditures-30.52-41.59-35.82-34.32-31.32-59.80
Net Assets From Acquisitions0.000.000.000.00-16.60-0.69
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.300.00-0.700.00-0.800.74
Purchase of Investments-0.300.00-0.700.00-0.800.00
Sale Or Maturity of Investments0.000.000.000.000.000.74
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.06
Cash from Investing Activities-30.82-41.59-36.52-34.32-48.72-59.70
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.420.880.401.100.520.70
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.420.880.401.100.520.70
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-550.63
Change in Long Term Debt0.000.000.000.000.00-550.63
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.00-550.63
Net Financing Active Other Cash Flow0.000.00-2.850.000.000.00
Other Financing Activities Uses0.000.00-2.850.000.000.00
Cash from Financing Activities0.420.88-2.451.100.52-549.93
Exchange Rate Effect-0.49-0.34-0.890.31-0.324.49
Net Change in Cash75.5623.61-30.3554.8446.63-513.71
Free Cash Flow105.2463.737.8685.1292.8890.16
Price to Free Cash Flow4.036.153.544.424.965.25

Revenue breakdown

Access Fees2024: 2.22B 2025: 2.09B
Other2024: 354.35M 2025: 438.04M
Non-US2024: 409.62M 2025: 458.24M
United States2024: 2.16B 2025: 2.07B
BetterHelp2024: 1.04B 2025: 950.37M
Teladoc Health Integrated Care2024: 1.53B 2025: 1.58B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3017.79%32.2M181.0M4.16M
2026-10-1517.78%32.1M180.4M4.29M
2026-09-3016.69%30.1M180.4M4.35M
2026-09-1515.32%27.6M180.4M4.59M
2026-08-3114.05%25.3M180.4M4.69M
2026-08-1413.27%23.7M178.5M4.85M
2026-07-3114.86%26.3M177.0M5.04M
2026-07-1515.95%28.1M175.9M4.76M
2026-06-3015.59%27.4M175.9M4.77M
2026-06-1516.74%29.4M175.9M4.68M
2026-05-2915.75%27.7M175.9M5.01M
2026-05-1515.07%26.5M175.9M5.46M
2026-04-3016.59%29.4M177.4M5.80M
2026-04-1516.94%29.7M175.4M6.14M
2026-03-3117.68%30.8M174.5M6.42M
2026-03-1318.33%32.0M174.5M6.35M
2026-02-2717.86%31.2M174.5M5.96M
2026-02-1317.61%30.6M173.6M5.93M
2026-01-3015.92%27.9M175.5M5.74M
2026-01-1514.14%24.8M175.5M6.32M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.507.457.607.4813.20529.008.000.996-0.0200.000
call2.006.507.456.6719.74517.000.000.996-0.0200.000
call2.506.456.856.5915.2594.001.000.982-0.0800.000
call3.005.506.455.6614.7156.000.000.978-0.0760.000
call3.505.505.705.679.0924.001.000.975-0.0780.000
call4.005.005.405.0410.5334.001.000.971-0.0770.000
call4.504.504.654.636.1387.002.000.967-0.0760.000
call5.004.004.154.125.6356.002.000.962-0.0730.001
call5.503.003.953.147.70118.000.000.956-0.0700.001
call6.003.003.152.743.9351220.000.949-0.0690.001
call6.502.092.922.475.55469.0010.000.940-0.0650.001
call7.002.002.222.093.33461.0011.000.928-0.0620.001
call7.501.441.601.381.5742254.000.911-0.0580.001
call8.000.851.100.901.12725162.000.884-0.0520.001
call8.500.330.720.521.4681861.000.808-0.0500.002
call9.000.200.250.180.7881,18525.000.573-0.0550.003
call9.500.040.060.070.7603768.000.301-0.0660.002
call10.000.010.030.011.00112242.000.099-0.0300.001
call10.500.000.200.011.48438.005.000.092-0.0410.001
call11.000.000.140.111.69410.001.000.065-0.0360.001
call11.500.000.120.071.9852.001.000.057-0.0390.001
call12.000.000.100.082.2550.001.000.051-0.0400.001
call12.500.000.220.002.5070.000.000.047-0.0420.001
call13.000.000.200.042.7440.002.000.044-0.0430.001
call13.500.000.220.002.9680.000.000.041-0.0440.001
call14.000.000.200.103.3340.002.000.048-0.0560.001
call14.500.000.220.003.5300.000.000.045-0.0570.001
call15.000.000.200.093.7261.001.000.044-0.0580.001
call15.500.000.220.003.9140.000.000.042-0.0590.001
call16.000.000.220.104.1170.000.000.040-0.0600.001
call16.500.000.100.104.2460.001.000.039-0.0600.001
call17.000.000.020.043.6120.001.000.013-0.0200.000
put1.500.000.010.018.8857.000.00-0.004-0.0140.000
put2.000.000.010.0811.8806.000.00-0.015-0.0770.000
put2.500.000.220.0010.3300.000.00-0.018-0.0790.000
put3.000.000.220.008.9510.000.00-0.022-0.0790.000
put3.500.000.220.007.7990.000.00-0.025-0.0780.000
put4.000.000.220.136.8081.000.00-0.029-0.0760.000
put4.500.000.220.045.9362.000.00-0.033-0.0750.000
put5.000.000.220.175.1562.000.00-0.038-0.0730.001
put5.500.000.220.084.44618.000.00-0.044-0.0710.001
put6.000.000.220.403.7935.000.00-0.051-0.0680.001
put6.500.000.220.003.1820.000.00-0.060-0.0650.001
put7.000.000.200.102.60653.005.00-0.073-0.0610.001
put7.500.000.120.062.05272.005.00-0.090-0.0570.001
put8.000.000.120.031.51163.000.00-0.117-0.0510.001
put8.500.020.060.090.9844570.00-0.184-0.0480.002
put9.000.150.180.220.83458210.00-0.427-0.0540.003
put9.500.350.780.601.9809.000.00-0.703-0.0660.002
put10.000.831.341.162.83510.0013.00-0.902-0.0290.001
put10.501.391.871.603.4118.0013.00-0.908-0.0400.001
put11.001.852.222.363.1899.000.00-0.922-0.0430.001
put11.502.332.542.452.6533.001.00-0.943-0.0370.001
put12.002.593.502.965.3950.000.00-0.949-0.0390.001
put12.503.054.000.005.6400.000.00-0.943-0.0500.001
put13.003.654.453.905.7581.000.00-0.946-0.0510.001
put13.504.055.004.406.3061.000.00-0.950-0.0530.001
put14.004.905.154.994.8281.002.00-0.961-0.0440.001
put14.505.355.705.605.3171.002.00-0.955-0.0550.001
put15.005.806.256.036.0060.001.00-0.956-0.0570.001
put15.506.256.856.796.6531.000.00-0.958-0.0570.001
put16.006.907.107.005.5282.001.00-0.960-0.0590.001
put16.507.407.607.575.57510.000.00-0.961-0.0590.001
put17.007.908.058.035.17713.001.00-0.978-0.0340.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-033Initial statement of beneficial ownership of securities2026-11-02SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-08SCHEDULE 13GSEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-258-KCurrent report2026-09-24SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-03144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-013Initial statement of beneficial ownership of securities2026-08-31SEC
2026-08-318-KCurrent report2026-08-27SEC
2026-08-138-KCurrent report2026-08-10SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-043Initial statement of beneficial ownership of securities2026-08-03SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100270.77K1
2026-10003.70K1
2026-0900359.03K6
2026-080000
2026-070052.19K3
2026-0600575.06K9
2026-050000
2026-04003.45K1
2026-0300683.77K4
2026-020000
2026-01005.42K1
2025-1200286.04K6
2025-1169.40K100

Institutional holders

Manager% owned
BlackRock, Inc.8.99%
VANGUARD PORTFOLIO MANAGEMENT LLC7.03%
DIMENSIONAL FUND ADVISORS LP5.01%
Point72 Asset Management, L.P.4.56%
RENAISSANCE TECHNOLOGIES LLC4.47%
Voss Capital, LP4.46%
VANGUARD CAPITAL MANAGEMENT LLC4.41%
STATE STREET CORP2.75%
AMERICAN CENTURY COMPANIES INC2.71%
Allianz Asset Management GmbH2.59%

Funds

Fund% owned
iShares Convertible Bond ETF11.53%
Calamos Market Neutral Income Fund9.00%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF8.42%
NYLIM MacKay Convertible Fund3.96%
Avantis U.S. Small Cap Value ETF3.88%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.15%
iShares Russell 2000 ETF2.64%
VANGUARD SMALL-CAP INDEX FUND2.30%
PIMCO RAE US Small Fund1.67%
VANGUARD SMALL-CAP VALUE INDEX FUND1.45%

OakChart. TDOC. Cached 15 minutes.